Skip to main content
Top
Published in: Journal of Endocrinological Investigation 2/2015

01-02-2015 | Original Article

A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances

Authors: F. Ramezani Tehrani, S. Behboudi-Gandevani, M. Simbar, F. Azizi

Published in: Journal of Endocrinological Investigation | Issue 2/2015

Login to get access

Abstract

Purpose

To evaluate the association of idiopathic hirsutism, insulin resistance and metabolic disorders.

Methods

Participants of this study included 137 women with idiopathic hirsutism and 698 women as controls selected from two large population-based cross-sectional studies including 1,772 reproductive-aged women. Anthropometric and biochemical characteristics of the participants were measured and compared; for instance, insulin resistance was estimated through the homeostatic model assessment and the metabolic syndrome was detected using the Joint Interim Statement.

Results

Mean age, body mass index and other anthropometric measures including waist and hip circumferences were statistically higher in women with idiopathic hirsutism. No differences were observed in blood pressure, glucose and lipid profiles, homeostatic model assessment or the prevalence of insulin resistance, obesity and metabolic syndrome in women with idiopathic hirsutism and controls after adjustment of age and body mass index. In the subgroup of women with metabolic syndrome, fasting glucose levels of those with idiopathic hirsutism were significantly higher than controls, after adjustment of age and body mass index as 114 ± 25.85 vs. 103.52 ± 41.90 mg/dL, P = 0.003. Furthermore, the age and body mass index-adjusted prevalence of impaired fasting glucose in women with idiopathic hirsutism were higher than controls as 16.8 vs. 4.6 %, OR = 2.26, 95 % CI 1.59–5.38. A threshold of 74.5 cm for waist circumference had the optimal combined sensitivity and specificity for prediction of insulin resistance in women with idiopathic hirsutism, though this value was 90.5 cm for controls.

Conclusions

Our data suggest that although the overall metabolic characteristics were similar in women with idiopathic hirsutism and controls, glycemic disturbances were more often seen in those suffered from metabolic syndrome and idiopathic hirsutism simultaneously.
Literature
1.
go back to reference SomaniN Harrison S, Bergfeld WF (2008) The clinical evaluation of hirsutism. Dermatol Ther 21:376–391CrossRef SomaniN Harrison S, Bergfeld WF (2008) The clinical evaluation of hirsutism. Dermatol Ther 21:376–391CrossRef
3.
go back to reference DeUgarte CM, Woods K, Bartolucci A, Azziz R (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91:1345–1350PubMedCrossRef DeUgarte CM, Woods K, Bartolucci A, Azziz R (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91:1345–1350PubMedCrossRef
4.
go back to reference Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488PubMedCrossRef Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488PubMedCrossRef
5.
go back to reference Sawaya M, Shalita A (1998) Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 3:9–15PubMed Sawaya M, Shalita A (1998) Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 3:9–15PubMed
7.
go back to reference Weger N, Schlake T (2005) Igf-I signalling controls the hair growth cycle and the differentiation of hair shafts. J Invest Dermatol 125:873–882PubMedCrossRef Weger N, Schlake T (2005) Igf-I signalling controls the hair growth cycle and the differentiation of hair shafts. J Invest Dermatol 125:873–882PubMedCrossRef
8.
go back to reference Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486PubMed Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486PubMed
9.
go back to reference FattahNS Abdel, Darwish YW (2009) Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism? Br J Dermatol 160:1011–1015CrossRef FattahNS Abdel, Darwish YW (2009) Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism? Br J Dermatol 160:1011–1015CrossRef
10.
go back to reference Sadat Hosseini M, Ramezani Tehrani F, Azizi F (2013) The lack of association between idiopathic hirsutism and metabolic disturbances: iranian PCOS Prevalence Study. Gynecol Endocrinol 29:821–825PubMedCrossRef Sadat Hosseini M, Ramezani Tehrani F, Azizi F (2013) The lack of association between idiopathic hirsutism and metabolic disturbances: iranian PCOS Prevalence Study. Gynecol Endocrinol 29:821–825PubMedCrossRef
11.
go back to reference Sarac F, Saygili F, Özgen G, Tuzun M, Yılmaz C, Kabalak T (2006) Assessment of insulin resistance in the idiopathic hirsutism. Gynecol Obstet Invest 63:126–131PubMedCrossRef Sarac F, Saygili F, Özgen G, Tuzun M, Yılmaz C, Kabalak T (2006) Assessment of insulin resistance in the idiopathic hirsutism. Gynecol Obstet Invest 63:126–131PubMedCrossRef
12.
go back to reference Ucak S, Basat O, Satir E, Altuntas Y (2011) Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients. Endocr J 59:291–296CrossRef Ucak S, Basat O, Satir E, Altuntas Y (2011) Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients. Endocr J 59:291–296CrossRef
13.
go back to reference Kr Ünlühizarci, Karababa Y, Bayram F, Kelestimur F (2004) The investigation of insulin resistance in patients with idiopathic hirsutism. J Clin Endocrinol Metab 89:2741–2744CrossRef Kr Ünlühizarci, Karababa Y, Bayram F, Kelestimur F (2004) The investigation of insulin resistance in patients with idiopathic hirsutism. J Clin Endocrinol Metab 89:2741–2744CrossRef
14.
go back to reference Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F (2011) The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 9:39PubMedCentralPubMedCrossRef Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F (2011) The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 9:39PubMedCentralPubMedCrossRef
15.
go back to reference Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F (2014) To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol 174:100–105PubMedCrossRef Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F (2014) To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol 174:100–105PubMedCrossRef
16.
go back to reference Azziz R, Carmina E, Sawaya ME (2000) Idiopathic hirsutism 1. Endocr Rev 21:347–362PubMed Azziz R, Carmina E, Sawaya ME (2000) Idiopathic hirsutism 1. Endocr Rev 21:347–362PubMed
17.
go back to reference Motala A, Esterhuizen T, Pirie FJ, Omar MA (2011) The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care 34:1032–1037PubMedCentralPubMedCrossRef Motala A, Esterhuizen T, Pirie FJ, Omar MA (2011) The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care 34:1032–1037PubMedCentralPubMedCrossRef
18.
go back to reference Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East the National Survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32:1092–1097PubMedCentralPubMedCrossRef Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East the National Survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32:1092–1097PubMedCentralPubMedCrossRef
19.
go back to reference Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753–759PubMedCrossRef Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753–759PubMedCrossRef
20.
go back to reference Pache T, Wladimiroff J, Hop W, Fauser B (1992) How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 183:421–423PubMedCrossRef Pache T, Wladimiroff J, Hop W, Fauser B (1992) How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 183:421–423PubMedCrossRef
21.
go back to reference Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef
23.
go back to reference Venkataraman K, Khoo CM, Leow MK, Khoo EY, Isaac AV, Zagorodnov V, Sadananthan SA, Velan SS, Chong YS, Gluckman P, Lee J, Salim A, Tai ES, Lee YS (2013) New measure of insulin sensitivity predicts cardiovascular disease better than HOMA estimated insulin resistance. PLoS ONE 30(8):e74410CrossRef Venkataraman K, Khoo CM, Leow MK, Khoo EY, Isaac AV, Zagorodnov V, Sadananthan SA, Velan SS, Chong YS, Gluckman P, Lee J, Salim A, Tai ES, Lee YS (2013) New measure of insulin sensitivity predicts cardiovascular disease better than HOMA estimated insulin resistance. PLoS ONE 30(8):e74410CrossRef
24.
go back to reference Rossi R, Tauchmanova L, Luciano A, Valentino R, Savastano S, Battista C, Di Martino M, Lombardi G (2000) Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism. J Endocrinol Invest 24:491–498CrossRef Rossi R, Tauchmanova L, Luciano A, Valentino R, Savastano S, Battista C, Di Martino M, Lombardi G (2000) Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism. J Endocrinol Invest 24:491–498CrossRef
25.
go back to reference Shoupe D, Lobo R (1984) The influence of androgens on insulin resistance. Fertil Steril 41:385–388PubMed Shoupe D, Lobo R (1984) The influence of androgens on insulin resistance. Fertil Steril 41:385–388PubMed
26.
go back to reference Sung YA, Oh JY, Chung H, Lee H (2014) Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome. Fertil Steril 101:840–845PubMedCrossRef Sung YA, Oh JY, Chung H, Lee H (2014) Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome. Fertil Steril 101:840–845PubMedCrossRef
27.
go back to reference Toprak S, Yonem A, Cakir B, Guler S, Azal O, Ozata M, Corakci A (2001) Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 55:65–70PubMedCrossRef Toprak S, Yonem A, Cakir B, Guler S, Azal O, Ozata M, Corakci A (2001) Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 55:65–70PubMedCrossRef
28.
go back to reference Ahrén B (2007) Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects. Diabetes Care 30:644–648PubMedCrossRef Ahrén B (2007) Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects. Diabetes Care 30:644–648PubMedCrossRef
29.
go back to reference Riccardi G, Giacco R, Rivellese A (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23:447–456PubMedCrossRef Riccardi G, Giacco R, Rivellese A (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23:447–456PubMedCrossRef
30.
go back to reference Lebovitz HE, Banerji MA (2005) Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 28:2322–2325PubMedCrossRef Lebovitz HE, Banerji MA (2005) Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 28:2322–2325PubMedCrossRef
31.
go back to reference Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM (2007) Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 56:992–997PubMedCrossRef Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM (2007) Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 56:992–997PubMedCrossRef
32.
go back to reference Park YM, Kwon HS, Lim SY, Lee JH, Yoon KH, Son HY, Yim HW, Lee WC (2010) Optimal waist circumference cutoff value reflecting insulin resistance as a diagnostic criterion of metabolic syndrome in a nondiabetic Korean population aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC) study. Yonsei Med J 51:511–518PubMedCentralPubMedCrossRef Park YM, Kwon HS, Lim SY, Lee JH, Yoon KH, Son HY, Yim HW, Lee WC (2010) Optimal waist circumference cutoff value reflecting insulin resistance as a diagnostic criterion of metabolic syndrome in a nondiabetic Korean population aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC) study. Yonsei Med J 51:511–518PubMedCentralPubMedCrossRef
33.
go back to reference Meigs JB, Williams K, Sullivan LM, Hunt KJ, Haffner SM, Stern MP, Villalpando CG, Perhanidis JS, Nathan DM, D’Agostino RB (2004) Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care 27:1417–1426PubMedCrossRef Meigs JB, Williams K, Sullivan LM, Hunt KJ, Haffner SM, Stern MP, Villalpando CG, Perhanidis JS, Nathan DM, D’Agostino RB (2004) Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care 27:1417–1426PubMedCrossRef
34.
go back to reference Škrha J, Ts Haas, Šindelka G, Prázný M, Widimský Ji, Cibula D, Svačina S (2004) Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab 89:135–141PubMedCrossRef Škrha J, Ts Haas, Šindelka G, Prázný M, Widimský Ji, Cibula D, Svačina S (2004) Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab 89:135–141PubMedCrossRef
35.
go back to reference Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405–441PubMedCrossRef Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405–441PubMedCrossRef
Metadata
Title
A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances
Authors
F. Ramezani Tehrani
S. Behboudi-Gandevani
M. Simbar
F. Azizi
Publication date
01-02-2015
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 2/2015
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0164-8

Other articles of this Issue 2/2015

Journal of Endocrinological Investigation 2/2015 Go to the issue

Thanks to Reviewers

Thanks to Reviewers 2014

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.